Increased risk of digital vascular events in scleroderma patients who have both anti‐centromere and anti‐interferon‐inducible protein 16 antibodies
Conclusion: Scleroderma patients who are double‐positive for antibodies recognizing CENP and IFI‐16 are significantly more likely to have significant digital vascular events during the course of their disease. This study provides further evidence that anti‐CENP and anti‐IFI‐16 antibodies are disease biomarkers that may be used for risk stratification of vascular events in scleroderma. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Zsuzsanna H. McMahan, Fredrick M. Wigley, Livia Casciola‐Rosen Tags: Brief Report Source Type: research
More News: Arthritis | Gangrene | Raynaud's Phenomenom | Rheumatology | Scleroderma | Smokers | Study